The estimated Net Worth of Amir Ali Talasaz is at least $405 Milion dollars as of 30 June 2024. Mr. Talasaz owns over 11,462 units of Guardant Health Inc stock worth over $54,828,128 and over the last 6 years he sold GH stock worth over $349,084,861. In addition, he makes $914,906 as Chairman of the Board, President oraz Chief Operating Officer at Guardant Health Inc.
AmirAli has made over 38 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 11,462 units of GH stock worth $285,060 on 30 June 2024.
The largest trade he's ever made was exercising 565,192 units of Guardant Health Inc stock on 1 January 2021 worth over $14,056,325. On average, AmirAli trades about 107,541 units every 45 days since 2018. As of 30 June 2024 he still owns at least 2,204,589 units of Guardant Health Inc stock.
You can see the complete history of Mr. Talasaz stock trades at the bottom of the page.
AmirAli Talasaz Ph.D. serves as Chairman of the Board, President, Chief Operating Officer of the Company. Prior to founding our company, Dr. Talasaz held various positions at Illumina, Inc., including Senior Director of Diagnostics Research from October 2011 to June 2012, where he led the efforts for emerging clinical applications of next-generation genomic analysis. During that time, he developed different genomic technologies suitable for clinical applications. In March 2008, he founded Auriphex Biosciences, Inc., which focused on purification and genetic analysis of circulating tumor cells for cancer management. The technology was acquired by lllumina, Inc. in 2009. During his academic years, he led the Technology Development group at the Stanford Genome Technology Center. He received his Ph.D. degree in electrical engineering, M.S. degree in electrical engineering and M.S. degree in management science and engineering from Stanford University.
As the Chairman of the Board, President oraz Chief Operating Officer of Guardant Health Inc, the total compensation of AmirAli Talasaz at Guardant Health Inc is $914,906. There are 2 executives at Guardant Health Inc getting paid more, with Michael Wiley having the highest compensation of $2,216,070.
AmirAli Talasaz is 40, he's been the Chairman of the Board, President oraz Chief Operating Officer of Guardant Health Inc since 2017. There are 15 older and no younger executives at Guardant Health Inc. The oldest executive at Guardant Health Inc is Stanley Meresman, 73, who is the Independent Director.
Amir's mailing address filed with the SEC is 3100, Hanover Street, Palo Alto, Santa Clara County, California, 94306, United States.
Over the last 6 years, insiders at Guardant Health Inc have traded over $2,653,630,540 worth of Guardant Health Inc stock and bought 2,438,210 units worth $45,173,576 . The most active insiders traders include Bluebird (Cayman) Ltd Softb..., Bluebird (Cayman) Ltd Svf E... oraz Helmy Eltoukhy. On average, Guardant Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of $2,415,822. The most recent stock trade was executed by Kumud Kalia on 9 September 2024, trading 6,545 units of GH stock currently worth $162,774.
we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.
Guardant Health Inc executives and other stock owners filed with the SEC include: